Reconstitution of Molybdoenzymes with Bis-Molybdopterin Guanine Dinucleotide Cofactors by Kaufmann, Paul et al.
HAL Id: hal-01927909
https://hal-amu.archives-ouvertes.fr/hal-01927909
Submitted on 20 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Reconstitution of Molybdoenzymes with
Bis-Molybdopterin Guanine Dinucleotide Cofactors
Paul Kaufmann, Chantal Iobbi-Nivol, Silke Leimkuhler
To cite this version:
Paul Kaufmann, Chantal Iobbi-Nivol, Silke Leimkuhler. Reconstitution of Molybdoenzymes with
Bis-Molybdopterin Guanine Dinucleotide Cofactors. Metalloproteins, pp.141-152, 2019, Methods in
Molecular Biology, 978-1-4939-8863-1. ￿hal-01927909￿
 1 
Protocols for the insertion of the bis-molybdopterin guanine 
dinucleotide cofactor into apo-molybdoenzymes from the DMSO 
reductase family 
 
Paul Kaufmann1, Chantal Iobbi-Nivol2 and Silke Leimkühler1* 
 
From the 1Institute of Biochemistry and Biology, Department of Molecular Enzymology, University 
of Potsdam, 14476 Potsdam, Germany; 2Aix-Marseille University, CNRS, BIP UMR7281, 13402 
Marseille, France.  
 
*To whom correspondence should be addressed: 
Silke Leimkühler; Department of Molecular Enzymology, Institute of Biochemistry and Biology, 
University of Potsdam, Karl-Liebknecht-Str. 24-25, 14476 Potsdam, Germany; Tel.: +49-331-977-5603; 
Fax: +49-331-977-5128; E-mail: sleim@uni-potsdam.de 
 
 
 
Abstract 
 
Molybdoenzymes are ubiquitous, and play important roles in all kingdoms of life. The 
enzymes’ cofactors comprise the metal molybdenum, a special organic ligand system called 
molybdopterin (MPT), additional small ligands like water, hydroxide, oxo‐, sulfido- or 
selenido- functions and, in some enzymes, a coordination to the peptide chain of the protein 
via an amino acid ligand (e.g. serine, aspartate, cysteine or selenosysteine). The so-called 
molybdenum cofactor (Moco) is deeply buried in the protein at the end of a narrow funnel 
giving access only to the substrate. In 1974 an assay was developed by Nason and 
coworkers using the pleotrophic Neurospora crassa mutant nit-1 for the reconstitution of 
molybdoenzyme activities from crude extracts. These studies lead to the understanding that 
Moco is the common element in all molybdoenzymes from different organisms. The assay 
has been further developed since using specific molybdenum enzymes as source of Moco 
for the reconstitution of diverse purified apo-molybdoenzymes. Alternatively, the 
molybdenum cofactor can be synthesized in vitro from stable intermediates and can be 
inserted into apo-molybdoenzymes by the aid of specific Moco-binding chaperones. A 
general working protocol is described here for the insertion of the bis-molybdopterin 
guanine dunucleotide cofactor (bis-MGD) into its target molybdoenzyme using the example 
of Escherichia coli TMAO reductase. 
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1. Introduction 
Molybdenum is an essential trace element for bacteria, archaea and eukaryotes. In the cell, 
molybdenum is coordinated to the dithiolene group of the molybdenum cofactor (Moco) in 
almost all organisms (1). Only bacteria which are able to fix nitrogen coordinate 
molybdenum additionally in the iron molybdenum cofactor (FeMoco) which is exclusively 
found in nitrogenase (2). In contrast, more than 60 different enzymes binding the Moco 
were identified in the past (3). The vast majority of molybdoenzymes is found in bacteria 
and achaea while in animals and plants only four or five different enzymes, respectively, are 
present (4). The different Moco-containing enzymes are categorized on the basis of their 
molybdenum ligandation sphere, dividing them into three different enzyme families (5): the 
xanthine oxidase (XO) family, the sulfite oxidase (SO) family and the dimethylsulfoxide 
(DMSO) reductase family (Figure 1). Enzymes of the XO family contain in general a Moco 
with a MPT-MoVIOS(O-) ligand sphere, however, in bacteria the cofactor-core can also be 
present as molybdopterin cytosine dinucleotide cofactor (MCD) variant. Enzymes of the SO 
family contain a Moco with a MPT-MoVIO2Cys core, while enzymes of the DMSO reductase 
family comprise a Moco with a MGD2-MoVIXY core with X being either a sulfido-, selenido- 
or oxo-ligand and Y either being a hydroxo or amino acid ligand (Ser, Cys, Sec, or Asp). 
While eukaryotes produce only enzymes belonging to the SO and XO families, enzymes of all 
three families are present in prokaryotes with enzymes of the DMSO reductase family being 
the predominant ones. 
 
Figure 1: The families of molybdoenzymes. Shown are the different forms of the molybdenum cofactor 
(Moco, shown in the tri-oxo-form(6)) categorized into three different enzyme families are classified 
according to their coordination at the molybdenum atom: the xanthine oxidase, sulfite oxidase, and 
DMSO reductase families. The sulfite oxidase family is characterized by a MPT-MoVIO2Cys ligand 
sphere. The xanthine oxidase family contains a MPT-MoVIOS(O-) core (7). Here, the MPT core can be 
modified by an additional CMP nucleotide at the phosphate group, forming MCD. The DMSO 
reductase family contains a MGD2-MoVIXY core with Y being either a sulfido, selenido- or oxo- ligand 
and X either being a hydroxo or amino acid ligand (Ser, Cys, Sec, or Asp). 
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Nason et al. provided in 1974 the first biochemical evidence for a common cofactor to all 
Moco-containing enzymes, which was removed as a low molecular weight fraction from 
denatured Mo-enzymes of mammalian, plant or bacterial origin (8). After separation, the 
protein-free Moco fraction was subsequently incorporated into a cofactor-free apo-nitrate 
reductase from eukaryotes (nit-1 extract), thereby activating the enzyme. The totality of 
these studies led to the understanding that with the exception of nitrogenase, Moco is the 
common element in all molybdoenzymes from different organisms. In addition to 
demonstrating the universality of Moco, the nit-1 extract assays also demonstrated that 
Moco is very labile with a lifetime of only a few minutes after release from 
molybdoenzymes, making chemical characterization of active Moco difficult. Therefore, 
structural characterization of Moco was achieved through the analysis of stable degradation 
products (9). The chemical nature of Moco has been determined by Rajagopalan and 
coworkers in 1982 which revealed a reduced pterin with an unusual 6-alkyl side chain 
consisting of four carbons, a terminal phosphate ester and a unique dithiolene group critical 
for metal ligation (10). Later crystal structures of Mo-enzymes have demonstrated the 
existence of a third pyrano ring between the OH-group at C3' of the side chain and the 
pterin C7 atom (11-13). Once the pyrano ring is closed, a fully reduced hydrogenated pterin 
is formed. Because of the unique nature of the pterin in Moco, the metal-free form of the 
cofactor is called molybdopterin or metal-binding pterin (MPT), the latter reflects the fact 
that not only Mo but also W can be coordinated by this pterin scaffold.  
 
The biosynthesis of Moco has been revealed to be highly conserved in all organisms, which 
can be divided into three general steps, according to the stable biosynthetic intermediates 
that can be isolated (14) (Figure 2):  
1. the synthesis of cyclic pyranopterin monophosphate (cPMP) 
2. conversion of cPMP into MPT by introduction of two sulfur atoms   
3. insertion of molybdate to form Moco  
 
In prokaryotes, a fourth step involves the further modification of Moco by the addition of 
nucleotide monophosphates to the phosphate group of MPT, forming the bis-
molybdopterin-guanine dinucleotide (bis-MGD) or MCD cofactor variants of the DMSO 
reductase or XO families, respectively (15).  
While Nason and coworkers studied the reconstitution of apo-nitrate reductase from N. 
crassa, which belongs to the SO family of molybdoenzymes binding Mo-MPT (8), the first in 
vitro reconstitution of a bacterial enzyme of the DMSO reductase family with bis-MGD was 
reported in 1987 for nitrate reductase from Escherichia coli and was further optimized in 
the following decades showing that the activity of MobA is required for the assembly of the 
bis-MGD cofactor of nitrate reductase (16).  
Studies on the molybdoenzyme TMAO reductase (TorA) from E. coli showed, that MobA acts 
in conjunction with the specific chaperone TorD in bis-MGD insertion into apo-TorA (17).  
By binding to the core of the apo-molybdoenzyme partner TorA, TorD induces a 
conformational change of apo-TorA that becomes competent for Moco insertion (18). 
Further, TorD plays a role also in the last step of the Moco maturation by interacting with 
the MobA protein involved in bis-MGD formation (19). Thus, the chaperone acts as a 
facilitator to insert the synthesized bis-MGD cofactor into the binding site of apo-TorA (20). 
 4 
 
Figure 2: The biosynthesis of the molybdenum cofactors. Shown is a scheme of the biosynthetic pathway of 
Moco. The general pathway occurs via three conserved steps present in all organisms, the formation of cPMP, 
MPT and Mo-MPT, which are stable intermediates that can be isolated. Bacteria and Archaea contain a 4th step 
of Moco modification in which Mo-MPT is further modified by the addition of nucleotides, either GMP or CMP. 
Additionally, Moco can be further modified by the replacement of one oxo-ligand by a sulfido-ligand, forming 
the sulfido-containing Moco present in the xanthine oxidase family of molybdoenzymes. After synthesis, the 
different forms of Moco are specifically inserted into the target enzymes of each family, either directly (SO 
family) or by the aid of molecular chaperones (examples are gives in blue). 
 
After bis-MGD insertion into apo-TorA, final folding of TorA is accomplished by the release 
of TorD from the complex. TorD-like proteins accordingly were considered to be system-
specific chaperones dedicated to the respective molybdoenzyme. In total, studies on the 
biosynthesis of Moco and the requirement of specific chaperones for the insertion of the 
various Moco derivatives after their synthesis suggested that Moco is a labile molecule that 
does not exist in a protein-free form in the cell (9).  
Therefore, it was very surprizing that recent studies demonstrated that the complex bis-
MGD cofactor can be extracted from the protein and reinserted into an apo-
molybdoenzyme without the help of a chaperone (to be accepted). The investigations 
showed that under anoxic conditions bis-MGD is stable for 90 min in its protein-free form. 
Further, extracted bis-MGD can be inserted into an apo-molybdoenzyme without the help of 
a chaperone which facilitates folding after insertion.  
Since the reconstitution of the N. crassa nit-1 extract with molybdenum cofactors from the 
SO and XO family of molybdoenzymes have been described in detail, we are focusing on the 
reconstitution of isolated molybdoenzymes from the DMSO reductase family with bis-MGD 
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cofactors from cellular extracts, synthesized in vitro using MobA and TorD or direct 
insertion of intact bis-MGD by using apo-TorA. The major challenge for the insertion of bis-
MGD into apo-molybdoenzymes lies in the fact that bis-MGD is labile towards O2, thus, all 
reconstitution steps must be performed under strictly anaerobic conditions. 
2. Materials  
 
2.1 Purified proteins required 
A. Apo-TorA is expressed in a E. coli strain incapable of Moco biosynthesis (e.g. RK5200, 
∆moaA (21,22). A His6-tagged variant of TorA can be used to ensure simple 
purification (22). The purified protein is stored in 100 mM Tris-HCl, pH 7.2 at -80°C 
until usage. The concentration of the protein should be at least 200 µM. 
A. The E. coli MobA protein is expressed as described previously (23) as a His6-tagged 
variant and is stored in 100 mM Tris-HCl, pH 7.2 at -80°C until usage. The 
concentration of the MobA protein should be at least 100 µM 
B. The E. coli TorD protein is expressed as a His6-tagged variant and is stored in 
100 mM Tris-HCl, pH 7.2 at -80°C until usage (22). The concentration of the TorD 
protein should be at least 100 µM 
C. The protein used as bis-MGD source should be in a concentration of at least 300 µM 
in e.g. 100 mM Tris-HCl, pH 7.2 (or a buffer in which the protein is stable). 
Rhodobacter capsulatus formate dehydrogenase (RcFDH) turned out to be an 
excellent bis-MGD donor protein which is used for the description of the method 
here. RcFDH is expressed as described previously as a His6-tagged protein and 
stored in 75 mM phosphate buffer, pH 7.2 at -80°C until usage (24). The protein 
concentration should be around 600 µM, since the protein generally is only 50% 
loaded with bis-MGD. 
 
2.2 In vitro reconstitution of apo-TorA from soluble extracts 
1. Anoxic phosphate buffer 20 mM, pH 7 
2. Purified E. coli TorD protein in 20 mM phosphate buffer, pH 7 
3. Purified E. coli apo-TorA in 20 mM phosphate buffer, pH 7 
4. 40 mg/ml soluble extract of an E. coli strain with a deletion in the genes for TMAO 
reductase and DMSO reductase (e.g. LCB504), in 100µl in phosphate buffer, pH7 
5. Heat-block for Eppendorf tubes, electrophoresis system, a centrifuge and N2. 
 
2.2 Reconstitution of apo-TorA with in vitro synthesized bis-MGD 
1. Anoxic 100 mM Tris-HCl, pH 7.2 
2. Anoxic 50 mM GTP 
3. Anoxic 50 mM MgCl2 
4. Purified E. coli TorD protein in 100 mM Tris-HCl, pH 7.2 
5. Purified E. coli MobA protein in 100 mM Tris-HCl, pH 7.2 
6. Purified E. coli apo-TorA in 100 mM Tris-HCl, pH 7.2 
7. 300 µM purified Moco-donor molybdoenzyme from the SO (e.g. human or chicken 
sulfite oxidase) or XO family (e.g. bovine XO purchased from sigma), in 100 mM Tris-
HCl, pH 7.2 
8. Heat-block for Eppendorf tubes, a centrifuge and an anaerobic chamber (Coy chamber 
or comparable) suitable for work under an oxygen-free atmosphere 
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2.3 Reconstitution of apo-TorA with bis-MGD isolated from a donor protein 
1. Anoxic 100 mM Tris-HCl, pH 7.2 
2. Purified bis-MGD containing enzyme in a concentration of 300 µM (e.g. RcFDH) 
3. Heat-block for Eppendorf tubes, a centrifuge and an anaerobic chamber (Coy 
chamber or comparable) suitable for work under an oxygen-free atmosphere 
3. Methods 
 
Scheme 1 
 
3.1 In vitro reconstitution of apo-TorA with soluble extracts 
O2 free atmosphere can be obtained by bubbling N2 gas in Eppendorf tubes containing E. 
coli extracts or purified protein. However, the yield of reconstitution is lower as compared 
to using an anaerobic chamber.  
1. E. coli cells from a strain LCB 440 (18) containing a deletion of the tor and dms operons 
grown anaerobically until the late exponential phase at 37°C 
2. After centrifugation, the cells are resuspended in 20 mM phosphate buffer, pH 7 to 5 ml 
per g of cells 
3. Cell lysis by French press or sonication, centrifugation for 20 min at 15,000 rpm 
4. Discard the pellet, the supernatant is centrifuged in an ultracentrifuge for 90 min 45,000 
rpm 
5. Adjust the protein concentration to 30 - 40 mg/ml with 20 mM phosphate buffer, pH 7 
6. Keep the supernatant at 4 °C under nitrogen atmosphere 
7. Mix in an Eppendorf tube:  
 - 0.5 µM apo-TorA,  
 - 100 µl soluble extract (as bis-MGD source)  
 - 2.3 µM TorD  
8. Adjust to a final volume of 150 µl with 20 mM phosphate buffer, pH 7 
9. Keep for 2 hours at 37 °C under nitrogen atmosphere 
10. The efficiency of the reconstitution can be checked by measuring the TorA activity in a 
spectrophotometric assay using benzyl viologen as electron donor 
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3.2 Reconstitution of apo-TorA  in native gels 
1. Mix in an Eppendorf tube:  
 - 1.5 µM apo-TorA  
 - 26.6 µM TorD  
2. Adjust the final volume to 20 µl with 20 mM phosphate buffer, pH 7 
3. Incubate for 1.5 hours at 37 °C, under nitrogen atmosphere 
 
Native PAGE: 
- Add 10 µl of non-denaturing loading buffer (200 mM Tris-HCl, pH 8.8, 5 mM EDTA, 1M 
sucrose, 0.1% bromophenol blue), do not boil the samples 
- Separate proteins on native 10% polyacrylamide gel 
- After separation, the polyacrylamide gel is incubated for 60 min at 37°C under nitrogen 
atmosphere, in 20 ml phosphate buffer containing 1 ml of bis-MGD source (1 ml soluble 
extract with a protein concentration of 40 mg/ml, preparation described above)  
- Transfer the polyacrylamide gel into 100 mM phosphate buffer, pH 6.5, containing 2 mM 
methyl viologen and 50 mM Na-dithionite in an anoxic atmosphere 
- When the gel turns dark blue, add 2 mM TMAO; active TorA will turn white in the gel, 
corresponding to the oxidation of reduced methyl viologen  
 
3.3 In vitro reconstritution of apo-TorA with direct bis-MGD cofactor sources 
In vitro reconstitution of apo-TMAO reductase with in vitro synthesized bis-MGD requires 
strict anaerobic conditions since Moco and its final product bis-MGD are highly sensitive to 
oxygen. All buffers, chemicals and proteins used need to be oxygen-free. We describe the 
preparation of samples i.e. in a Coy Chamber under a Nitrogen/Hydrogen atmosphere 
(95%/5%).  
 
3.3.1 In vitro reconstitution of apo-TorA with in vitro synthesized bis-MGD using 
MobA and TorD 
1. Anoxic 100 mM Tris-HCl, pH 7.2 buffer is prepared at least one day before the 
reconstitution procedure. The buffer is sterile filtered and degassed for at least 1 
hour followed by incubation in the Coy chamber for at least 12 hours to remove all 
oxygen.  
2. For enzymatic hydrolysis of GTP magnesium chloride is required. A 50 mM MgCl2 
solution is prepared, degassed as described in step 1 and incubated in the Coy 
chamber for at least 12 hours to remove residual oxygen. 
3. On the day of reconstitution, 200 µM apo-TorA, 100 µM MobA protein in addition to 
the Moco donor protein in a concentration of 300 µM are incubated in the Coy 
chamber for at least 2 hours at 4 °C. In 2 ml Eppendorf tubes, GTP powder for a 
50 mM stock solution is transferred to the Coy Chamber and incubated for at least 2 
hours at 4 °C. 
4. Extraction of Moco requires heat-denaturation of the donor protein. The donor 
protein needs to be diluted to 30 µM with the anoxic 100 mM Tris-HCl buffer, pH 7.2 
in a total volume of 400 µl. The denaturation of the protein is carried out at 95°C for 
4 minutes followed by centrifugation of the samples at 13,000 g for a minimum of 
90 seconds. The supernatant is removed carefully and should not be stored for 
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longer than 30 minutes under anoxic conditions. Long-term storage of isolated 
Moco is not recommended and will decrease the reconstitution efficiency.  
5. The in vitro biosynthesis and simultaneous incorporation of bis-MGD into apo-TorA 
is started by mixing of 200 µl Moco-containing supernatant with 6 µl 50 mM GTP 
and 6 µl 50 mM MgCl2 (final concentration = 1 mM), 6 µl 100 µM MobA protein 
(2 µM final concentration), 6 µl 100 µM TorD protein and 20 µl 20 µM apo-TorA. 
Final volume of 300 µl is adjusted by addition of 62 µl of anoxic 100 mM Tris-HCl, 
pH 7.2. The reconstitution mixture needs to be incubated at 37°C for 7.5 hours 
under anoxic conditions. When higher end-concentrations of reconstituted TorA are 
required, the volume of the reaction can be generally scaled up, but it is important 
to keep the concentrations of all compounds as described above. An increase of the 
protein concentrations will result in a decreased reconstitution efficiency. 
6. The reconstitution can be performed in the absence of TorD. The efficiency of the 
reconstitution is about 40% more effective when TorD protein is present in the 
assay. 
7. After reconstitution the reconstituted active TMAO reductase needs to be purified 
from the reaction mixture to remove all low molecular weight compounds in 
addition to TorD and MobA. Gel filtration on a Superdex 200 or Superose 12 column, 
depending on the amount of sample, proved to be the method of choice.  
 
3.3.2 In vitro reconstitution of apo-TMAO reductase with bis-MGD extracted from 
a DMSO-reductase family donor protein. 
For reconstitution of apo-TorA with bis-MGD isolated from a bis-MGD containing donor 
protein, the MobA or TorD proteins are not required.  
1. Anoxic 100 mM Tris-HCl, pH 7.2 buffer are prepared at least one day before the 
reconstitution procedure. After preparation, the buffer is sterile filtered and 
degassed for at least 1 hour followed by incubation in the Coy chamber for at least 
12 hours to remove all oxygen.  
2. On the day of reconstitution procedure 200 µM apo-TorA and 600 µM RcFDH are 
incubated in the Coy chamber for at least 2 hours at 4 °C.  
3. Extraction of Moco requires heat-denaturation of the donor protein. The donor 
protein RcFDH is diluted to 30 µM with the anoxic 100 mM Tris-HCl buffer in a total 
volume of 400 µl (1:20). The denaturation of the protein is carried out at 95 °C for 4 
minutes followed by centrifugation of the samples at 13,000 g for a minimum of 90 
seconds. The supernatant is removed carefully and should not be stored for longer 
than 30 minutes under anoxic conditions. Long term storage of isolated Moco is not 
recommended and will decrease the reconstitution efficiency. The pellet of 
denatured RcFDH appears black, whereas the supernatant has a yellowish color. 
4. The in vitro reconstitution of apo-TorA with bis-MGD is started by mixing 280 µl of 
the bis-MGD-containing supernatant with 20 µl of 20 µM apo-TorA. The 
reconstitution mixture is incubated at 37 °C for 7.5 hours under anoxic conditions.  
5. After reconstitution, the activated TMAO reductase needs to be purified from the 
reaction mixture to remove all low molecular weight compounds. Gel filtration on a 
Superdex 200 or Superose 12 column, depending on the amount of sample, proved 
to be the method of choice.  
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6. TorD is not required for the insertion of bis-MGD into apo-TorA, therefore the 
reconstitution with extracted bis-MGD is described without TorD.  
 
4. Notes 
A. From preparation to preparation, and especially for TorA reconstituted with Moco 
from different Moco donors, the amount of incorporated bis-MGD into apo-TorA 
reductase will vary. To make all samples comparable, the relative FormA-GMP 
(stable and fluorescent oxidation product of MGD) has to be determined for each 
sample. Specific activities of reconstituted TorA can be correlated to FormA-GMP 
content per mg of enzyme to result in specific activities per unit of MGD (U/MGD) 
B. TMAO reductase of E. coli is highly stable in its holo form, whereas the apo form has 
moderate stability. Thus, removal of unreconstituted protein can be achieved by 
incubation of the reconstituted protein at 65 °C for 90 seconds with subsequent 
centrifugation at 13,000 g for 10 minutes. Apo-TorA will precipitate, whereas the 
holo-protein remains stable. 
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